Log in to save to my catalogue

Comment on ‘Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients a...

Comment on ‘Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f324324e12e04d26abffb1289a0594ab

Comment on ‘Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types’

About this item

Full title

Comment on ‘Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types’

Author / Creator

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2025-03, Vol.13 (3), p.e011943

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Future studies should further validate TMB thresholds in multi-ethnic cohorts and align with harmonization efforts such as the Friends of Cancer Research TMB Harmonization Project, which emphasizes minimum panel size (>667 kb) and standardized filtering.3 Unexplored mechanisms behind microsatellite stable (MSS) colorectal cancer (CRC) exception The...

Alternative Titles

Full title

Comment on ‘Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types’

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f324324e12e04d26abffb1289a0594ab

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f324324e12e04d26abffb1289a0594ab

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1136/jitc-2025-011943

How to access this item